The Effects of the Early and Late Phases of Septic Shock on the Population Pharmacokinetics of Vancomycin
The Journal of Clinical Pharmacology · 2025
DOI: 10.1002/jcph.70009 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2025. Verfasst von Tanisa Lexnoi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacy, Department of Pharmacy, Chonburi Hospital, Muang, Chonburi, Thailand. Hauptthemen laut MEDLINE: Vancomycin, Shock, Septic, Anti-Bacterial Agents, Models, Biological. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Research Fund of Faculty of Pharmaceutical Sciences, Prince of Songkla University, Thailand Science Research and Innovation Fund and the University of Phayao.
Themen: Sepsis
Abstract (Originalsprache)
Pathophysiologic changes in the early and late phases of septic shock affect the pharmacokinetic (PK) parameters, varying dose adjustments may be necessary. This study aimed to create the PK models of vancomycin in the early and late phases of septic shock and to describe the association between the area under the curve from 0 to 24 h (AUC 0‐24 ) and acute kidney injury (AKI). The data from patients with septic shock receiving vancomycin was collected either prospectively or retrospectively. A nonlinear mixed‐effects modeling approach was used to develop the PK models. A total of 208 septic shock patients were enrolled and classified into the early (n = 96) and the late phase (n = 112). A two‐compartment PK model is the best base model for both phases of septic shock. The model that best predicted the clearance (CL) of both phases was the 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI) creatinine equation, which was not indexed to body surface area (BSA). Albumin (ALB) was a covariate associated with vancomycin CL only in the late phase. The typical values of CL and volume of distribution (V d ) in the early phase were 1.71 L/h and 68.94 L. In the late phase, CL was 1.65 L/h, and V d was 66.36 L. The AKI was observed in patients with a high simulated AUC 0‐24 . The population PK model of vancomycin in the early and late phases of septic shock has been established. The CKD‐EPI not indexed to BSA predicts vancomycin CL in both phases. ALB was associated with CL in the late phase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Pharmacy, Department of Pharmacy, Chonburi Hospital, Muang, Chonburi, Thailand.
- School of Pharmaceutical Sciences, University of Phayao, Muang, Phayao, Thailand.
- Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakorn Pathom, Thailand.
- Division of Pulmonary and Critical Care, Department of Medicine, Chonburi Hospital, Muang, Chonburi, Thailand.
- Division of Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Prince of Songkhla University, Hat Yai, Songkhla, Thailand.
- Division of Infectious Disease, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.
Förderung
- Research Fund of Faculty of Pharmaceutical Sciences, Prince of Songkla University
- Thailand Science Research and Innovation Fund and the University of Phayao
Zitieren
APA
Lexnoi, T., Boonpeng, A., Santimaleeworagun, W., Chaisiri, K., Dechsanga, J., Vattanavanit, V., Ungthammakhun, C., & Sitaruno, S. (2025). The Effects of the Early and Late Phases of Septic Shock on the Population Pharmacokinetics of Vancomycin. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.70009
Vancouver
Lexnoi T, Boonpeng A, Santimaleeworagun W, Chaisiri K, Dechsanga J, Vattanavanit V, et al. The Effects of the Early and Late Phases of Septic Shock on the Population Pharmacokinetics of Vancomycin. The Journal of Clinical Pharmacology. 2025. doi:10.1002/jcph.70009
BibTeX
@article{Lexnoi2025,
author = {Lexnoi, Tanisa and Boonpeng, Apinya and Santimaleeworagun, Wichai and Chaisiri, Kessarin and Dechsanga, Jutamas and Vattanavanit, Veerapong and Ungthammakhun, Chutchawan and Sitaruno, Sirima},
title = {The Effects of the Early and Late Phases of Septic Shock on the Population Pharmacokinetics of Vancomycin},
journal = {The Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1002/jcph.70009}
}
EUVIMED